Celltrion CARES Co-pay Program (Steqeyma)
Celltrion, Inc. · Steqeyma
Patient pays: as little as $0 for each dose
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Steqeyma assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Every Steqeyma program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Steqeyma (ustekinumab-stba) is an il-12/il-23 inhibitor (biologic biosimilar) made by Celltrion. It is commonly prescribed for: Plaque psoriasis, Psoriatic arthritis, Crohn's disease, Ulcerative colitis.
At a glance
As of July 2026, mendmeds tracks 2 Steqeyma assistance programs, 1 of which is open to patients with no insurance.
As of July 2026, 1 of the 2 Steqeyma assistance programs limits eligibility to households earning at or below 400% of the federal poverty level.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Celltrion, Inc. · Steqeyma
Patient pays: as little as $0 for each dose
commercial insurance
Celltrion, Inc. · Steqeyma
uninsured
Common questions
Related drugs